Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: A meta-analysis

Journal of Hypertension

Volumn 22, Issue 9, 2004, Pages 1655-1662

  Kosmas, Ioannis P ^a   Tatsioni, Athina ^a,b   Ioannidis, John P A ^a,b,c,d  

^a UNIVERSITY OF IOANNINA   (Greece)

^b TUFTS MEDICAL CENTER   (United States)

^c INSTITUTE OF COMPUTER SCIENCE   (Greece)

^d UNIVERSITY OF IOANNINA   (Greece)

Author keywords

C677T; Hypertensive disease of pregnancy; Methylenetetrahydrofolate reductase; Polymorphism; Pre eclampsia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ALLELE; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; EMBASE; FEMALE; HEREDITY; HUMAN; MATERNAL HYPERTENSION; MEDLINE; META ANALYSIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; RISK; SENSITIVITY ANALYSIS;

EID: 4344599724     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200409000-00004     Document Type: Article

References (56)

1. Walker JJ. Pre-eclampsia. Lancet 2000; 356:1260-1265.
2. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357:53-56.
3. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997; 34:525-526.
4. Powers RW, Minich LA, Lykins DL, Ness RB, Crombleholme WR, Roberts JM. Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J Soc Gynecol Investig 1999; 6: 74-79.
5. O'Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, Morris NH. Factor V Leiden and thermolibile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension 1999; 33:1338-1341.
6. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-113.
7. Fodinger M, Horl WH, Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol 2000; 13:20-33.
8. Morrison ER, Mledzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, et al. Prothrombotic genotypes are not associated with preeclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002; 87: 779-785.
9. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002; 101:6-14.
10. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127:820-826.
11. Pettiti D. Meta-analysis, decision analysis and cost-effectiveness analysis, 2nd edition. New York: Oxford University Press; 1999.
12. Ioannidis J, Lau J. Evolution of treatment effects over time: empirical insight from recursive cumulative meta-analyses. Proc Natl Acad Sci USA 2001; 98:831-836.
13. Ioannidis JP, Contopoulos-Ioannidis DG, Lau J. Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. J Clin Epidemiol 1999; 52: 281-291.
14. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634.
15. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001; 54:1046-1055.
16. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088-1101.
17. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, et al. The factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to pre-eclampsia. Thromb Haemost 1997; 77:1052-1054.
18. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Scianname N, Montanaro S, et al. Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria. Thromb Haemost 1999; 81:349-352.
19. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340:9-13.
20. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombotic mutations. Obstet Gynecol 2000; 96:45-49.
21. Glueck CJ, Kupfermine MJ, Fontaine RN, Wang P, Weksler BB, Eldor A. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001; 97:44-48.
22. Rigo J, Nagy B, Fintor L, Tanyi J, Beke A, Karadi I, Papp Z. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregn 2000; 19:163-172.
23. Nagy B, Toth T, Rigo J, Karadi I, Romics L, Papp Z. Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women. Clin Genet 1998; 53:478-481.
24. Rajkovic A, Mahomed K, Rozen R, Malinow MR, King IB, Williams MA. Methylenetetrahydrofolate reductase 677 C → T polymorphism, plasma folate, vitamin B(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe. Mol Genet Metab 2000; 69: 33-39.
25. Alfirevic Z, Mousa HM, Martlew V, Briscoe L, Perez-Casal M, Toh CH. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol 2001; 97:753-759.
26. Kim JY, Williamson RA, Murray JC, Andrews J, Pietscher JJ, Peraud PJ, Merill DC. Genetic susceptibility to preeclampsia: roles of cytosine-to-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine →-synthase, and factor V Leiden mutation. Am J Obstet Gynecol 2001; 184:1211-1217.
27. D'Elia AV, Driul L, Giacomello R, Colaone R, Fabbro D, Di Leonardo C, et al. Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia. Gynecol Obstet Invest 2002; 53:84-87.
28. Livingstone JC, Barton JR, Park V, Haddad B, Philips O, Sibai BM. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol 2001; 185: 153-157.
29. Prasmusinto D, Skrablin S, Hofstaetter C, Fimmers R, van der Ven K. The methylenetetrahydrofolate reductase 677 C → T polymorphism and preeclampsia in two populations. Obstet Gynecol 2002; 99:1085-1092.
30. Lauszus FF, Gron PL, Klebe JG. Association of polymorphism of methylene-tetrahydro-folate-reductase with urinary albumin excretion rate in type 1 diabetes mellitus but not with preeclampsia, retinopathy, and preterm delivery. Acta Obstet Gynecol Scand 2001; 80:803-806.
31. Raijmakers MT, Zusterzeel PL, Steegers EA, Peters WH. Hyperhomocysteinaemia: a risk factor for preeclampsia? Eur J Obstet Gynecol Reprod Biol 2001; 95:226-228.
32. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, Pals G, ten Kate LP, de Vries JI, et al. Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia. Am J Obstet Gynecol 2001; 184:394-402.
33. Laivuori H, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K. 677 C → T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia. Obstet Gynecol 2000; 96:277-280.
34. Chikosi AB, Moodley J, Pegoraro RJ, Lanning PA, Rom L. 5, 10 methylenetetrahydrofolate reductase polymorphism in black South African women with pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 1219-1220.
35. Kaiser T, Brennecke SP, Moses EK. C677T methylenetetrahydrofolate reductase polymorphism is not a risk factor for pre-eclampsia/eclampsia among Australian women. Hum Hered 2001; 51:20-22.
36. Kaiser T, Brennecke SP, Moses EK. Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia/eclampsia in Australian women. Gynecol Obstet Invest 2000; 50:100-102.
37. Kobashi G, Yamada H, Asano T, Nagano S, Hata A, Kishi R, et al. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese women. Am J Med Genet 2000; 93:122-125.
38. Prochazka M, Krcova V, Kudela M, Slavik L. Occurrence of gene mutations in factor V Leiden, prothrombin and methylenetetrahydrofolate reductase in patients with pre-eclampsia. Ceska Gynekol 2003; 68: 162-166.
39. Martinelli P, Grandone E, Colaizzo D, Paladini D, Scianname N, Margaglione M, Di Minno G. Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica 2001; 86:428-431.
40. Ioannidis JP. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trial. JAMA 1998; 279:281-286.
41. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337:867-872.
42. Dickersin K, Min YI, Meinert CL. Factors influencing publication of research results. Follow up of applications submitted to two institutional review boards. JAMA 1992; 267:374-378.
43. DeWolf F, Brosens I, Renaer M. Fetal growth retardation and the maternal arterial supply in the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980; 87:678-685.
44. Redman CWG. Current topic: pre-eclampsia and the placenta. Placenta 1991; 12:301-308.
45. Roberts JM, Taylor RM, Goldfein. A Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991; 4:700-708.
46. Stehouwer CD, van Guldener C. Does homocysteine cause hypertension? Clin Chem Lab Med 2003; 41:1408-1411.
47. Leeda M, Riyazi N, de Vries JI, Jakobs C, van Geijn HP, Dekker GA. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinaemia and a history of pre-eclampsia or fetal growth restriction. Am J Obstet Gynecol 1998; 179:135-139.
48. Khong T, Hague W. The placenta in hyperhomocysteinaemia. Br J Obstet Gynaecol 1999; 106:273-278.
49. Gebhardt GS, Hillerman R, Kotze MJ. Hyperhomocysteinaemia and fetal methylenetetrahydrofolate reductase gene status-does the fetus play a genetic role in the pathophysiology of pre-eclampsia? Hypertens Pregn 2002; 21(suppl 1):17.
50. Kosmas IP, Tatsioni A, Ioannidis JP. Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2003; 21:1221-1228.
51. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001; 29: 306-309.
52. Ioannidis JPA, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large vs. smaller studies: an empirical assessment. Lancet 2003; 361:567-571.
53. Barden AE, Herbison CE, Beilin LJ, Michael CA, Walters BN, Van Bockxmeer FM. Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy. J Hypertens 2001; 19:1775-1782.
54. Morgan L, Foster F, Hayman R, Crawshaw S, Baker PN, Pipkin FB, Kalsheker N. Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and pre-eclamptic pregnancies. J Hypertens 1999; 17:765-768.
55. Curnow KM, Pham T, August P. The L10F mutation of angiotensinogen is rare in pre-eclampsia. J Hypertens 2000; 18:173-178.
56. D'Aniello G, Florio P, Sabatini L, Severi FM, Fineschi D, Cito G, et al. The search for thrombophilic gene mutations in women with gestational hypertension does not help in predicting poor pregnancy outcome. J Hypertens 2003; 21:1915-1920.